Macquarie Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-82,248
Closed -$2.31M 1465
2025
Q3
$2.31M Buy
82,248
+21,474
+35% +$650K ﹤0.01% 1139
2025
Q2
$2.24M Buy
60,774
+16,568
+37% +$572K ﹤0.01% 1187
2025
Q1
$1.74M Sell
44,206
-158,294
-78% -$7.13M ﹤0.01% 1265
2024
Q4
$9.41M Buy
202,500
+101,176
+100% +$4.57M 0.01% 818
2024
Q3
$4.58M Buy
101,324
+43,308
+75% +$2.06M ﹤0.01% 984
2024
Q2
$2.86M Buy
+58,016
New +$2.37M ﹤0.01% 1115
2023
Q1
Sell
-9,252
Closed -$220K 1760
2022
Q4
$220K Sell
9,252
-7,127
-44% -$207K ﹤0.01% 1592
2022
Q3
$599K Sell
16,379
-10,680
-39% -$454K ﹤0.01% 1498
2022
Q2
$946K Sell
27,059
-2,329
-8% -$82.5K ﹤0.01% 1499
2022
Q1
$1.45M Sell
29,388
-123,384
-81% -$6.84M ﹤0.01% 1456
2021
Q4
$11.8M Sell
152,772
-11,932
-7% -$1.22M 0.01% 886
2021
Q3
$17.6M Buy
164,704
+58,925
+56% +$6.75M 0.02% 800
2021
Q2
$14.1M Buy
105,779
+85,811
+430% +$9.98M 0.01% 859
2021
Q1
$2.47M Buy
19,968
+18,850
+1,686% +$2.86M ﹤0.01% 1123
2020
Q4
$158K Sell
1,118
-399
-26% -$44.3K ﹤0.01% 1743
2020
Q3
$115K Sell
1,517
-66,239
-98% -$4.12M ﹤0.01% 1746
2020
Q2
$3.07M Buy
67,756
+66,020
+3,803% +$2.37M 0.01% 897
2020
Q1
$53K Buy
+1,736
New +$46.7K ﹤0.01% 1797

Other funds holding TWST

Macquarie Group's TWST Position: Q4 2025 in Review

Macquarie Group sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 82,248 shares — an estimated $2.31M sold.

Macquarie Group first reported a position in TWST in Q1 2020 and held it in 18 quarters. The position peaked at $17.6M in Q3 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Macquarie Group reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 82,248 Twist Bioscience shares in Q4 2025, an estimated $2.31M.
  • Macquarie Group first reported a position in Twist Bioscience in Q1 2020 and held it in 18 quarters.
  • Macquarie Group's Twist Bioscience position peaked at $17.6M in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.